These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 11031845)
1. [Meningococcal disease. The situation in Spain in the 1998-1999 period]. Cano Portero R; García Delgado C; de Mateo Ontañón S Rev Esp Salud Publica; 2000; 74(4):369-75. PubMed ID: 11031845 [TBL] [Abstract][Full Text] [Related]
2. [Meningococcal disease in Spain, 1990-1997. Change in its epidemiological pattern]. de Mateo Ontañón S Rev Esp Salud Publica; 2000; 74(4):387-96. PubMed ID: 11031848 [TBL] [Abstract][Full Text] [Related]
3. [Evolution of meningococcal disease in the community of Madrid. Effectiveness of antimeningococcal A+C vaccination]. Gutiérrez Rodríguez MA; Ramírez Fernández R; García Gutiérrez J; Moreno Civantos A; Hernando García M; Arce Arnáez A; Sendra Gutiérrez JM; Bueno Vallejos R Rev Esp Salud Publica; 2000; 74(4):397-403. PubMed ID: 11031849 [TBL] [Abstract][Full Text] [Related]
4. [Evolution of meningococcal infection among infant population in the autonomous community of Valencia (1996-2000). Effectiveness of A+C meningococcal vaccination]. Goicoechea Sáez M; Fullana Montoro AM; Momparler Carrasco P; Redondo Gallego MJ; Brines Solanes J; Bueno Cañigral FJ Rev Esp Salud Publica; 2003; 77(1):125-42. PubMed ID: 12696392 [TBL] [Abstract][Full Text] [Related]
5. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine. Cardeñosa N; Domínguez A; Martínez A; Alvarez J; Pañella H; Godoy P; Minguell S; Camps N; Vázquez JA; Infection; 2003 Dec; 31(6):392-7. PubMed ID: 14735381 [TBL] [Abstract][Full Text] [Related]
6. [Haemophilus influenzae type b invasive disease and meningococcal disease: incidence and characteristics in Barcelona, 1994-1995. Work Group IMS-IUSPC for Surveillance and Control of Meningitis]. Beni C; Caylà JA; Jansà JM; Maldonado R; Pañella H; Rajmil L; Villalbí JR Med Clin (Barc); 1999 Jan; 112(1):1-4. PubMed ID: 10027177 [TBL] [Abstract][Full Text] [Related]
7. Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei City, China. Ni JD; Jin YH; Dai B; Wang XP; Liu DQ; Chen X; Zheng Y; Ye DQ Postgrad Med J; 2008 Feb; 84(988):87-92. PubMed ID: 18322129 [TBL] [Abstract][Full Text] [Related]
8. Impact of the meningococcal C conjugate vaccine in Spain: an epidemiological and microbiological decision. Cano R; Larrauri A; Mateo S; Alcalá B; Salcedo C; Vázquez JA Euro Surveill; 2004 Jul; 9(7):11-5. PubMed ID: 15318008 [TBL] [Abstract][Full Text] [Related]
9. Meningococcal disease in Auckland, July 1992 - June 1994. Jefferies C; Lennon D; Stewart J; Martin D N Z Med J; 1999 Apr; 112(1085):115-7. PubMed ID: 10326799 [TBL] [Abstract][Full Text] [Related]
10. Changes in the evolution of meningococcal disease, 2001-2008, Catalonia (Spain). Martínez AI; Dominguez A; Oviedo M; Minguell S; Jansa JM; Codina G; Vazquez JA; Vaccine; 2009 May; 27(25-26):3496-8. PubMed ID: 19200816 [TBL] [Abstract][Full Text] [Related]
11. Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales. Ramsay M; Kaczmarski E; Rush M; Mallard R; Farrington P; White J Commun Dis Rep CDR Rev; 1997 Apr; 7(4):R49-54. PubMed ID: 9127510 [TBL] [Abstract][Full Text] [Related]
12. The impact of meningococcal serogroup C conjugate vaccine in Scotland. Mooney JD; Christie P; Robertson C; Clarke SC Clin Infect Dis; 2004 Aug; 39(3):349-56. PubMed ID: 15307001 [TBL] [Abstract][Full Text] [Related]
13. Meningococcal C vaccines: the Canadian experience. De Wals P Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070 [TBL] [Abstract][Full Text] [Related]
14. [The first effect of the national vaccination campaign against meningococcal-C disease: a rapid and sharp decrease in the number of patients]. de Greeff SC; de Melker HE; Spanjaard L; van den Hof S; Dankert J Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1132-5. PubMed ID: 12822525 [TBL] [Abstract][Full Text] [Related]
15. Meningococcal disease--management of serogroup C clusters in a hyperendemic area. Dell E; Bedford D; McMahon B; Nicholson A Ir Med J; 2001 Jun; 94(6):166, 168-9. PubMed ID: 11495231 [TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the vaccination campaign in Cantabria 2 years of epidemiological evolution]. González de Aledo A; García Merino J Rev Esp Salud Publica; 2000; 74(4):405-11. PubMed ID: 11031850 [TBL] [Abstract][Full Text] [Related]
17. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002. Brooks R; Woods CW; Benjamin DK; Rosenstein NE Clin Infect Dis; 2006 Jul; 43(1):49-54. PubMed ID: 16758417 [TBL] [Abstract][Full Text] [Related]
18. The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada. Bettinger JA; Scheifele DW; Le Saux N; Halperin SA; Vaudry W; Tsang R; Pediatr Infect Dis J; 2009 Mar; 28(3):220-4. PubMed ID: 19209096 [TBL] [Abstract][Full Text] [Related]
19. Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis. De Wals P; Coudeville L; Trottier P; Chevat C; Erickson LJ; Nguyen VH Vaccine; 2007 Jul; 25(29):5433-40. PubMed ID: 17560695 [TBL] [Abstract][Full Text] [Related]
20. Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York. Weiss D; Stern EJ; Zimmerman C; Bregman B; Yeung A; Das D; Dentinger CM; Marx MA; Kornblum J; Lee L; Halse TA; Mayer LW; Hatcher CP; Theodore MJ; Schmink S; Harcourt BH; Zucker JR; Layton M; Clark TA; Clin Infect Dis; 2009 Apr; 48(7):894-901. PubMed ID: 19231975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]